All articles by Frankie Fattorini

Frankie Fattorini

Frankie Fattorini is a healthcare and pharmaceutical reporter. His background is in genomics research, and he has also worked in medical communications. Frankie has written freelance articles on emerging technologies and various pieces on oncology and drug development.

AI could personalise clinical trial consent, but privacy concerns remain

Artificial intelligence (AI) is revolutionising clinical trials, offering ways to improve the consent process, but concerns regarding the complete reliability…
Clinician capacity remains a major bottleneck in UK’s push for cancer trials

While encouraged by revised regulations aimed at boosting UK clinical studies, experts say busy schedules of NHS workers present a…
ASCO25: Kura’s Phase II ziftomenib results trigger NDA acceptance from FDA

A November 2025 PDUFA date has been set for Kura Oncology’s oral acute myeloid leukaemia (AML) drug ziftomenib following the…
ASCO25: Amgen’s Nplate proves effective in GI cancer-linked thrombocytopaenia

Amgen’s Nplate (romiplostim) has demonstrated efficacy in treating thrombocytopaenia among gastrointestinal (GI) cancer patients, as Phase III RECITE results are…
ASCO25: J&J’s Carvykti shows strong efficacy across multiple myeloma risk groups

Updated analysis showed Carvykti (ciltacabtagene autoleucel) improved survival for multiple myeloma patients regardless of their cytogenetic risk or prior lines…

ASCO25: Pfizer’s Braftovi combo boasts 47% drop in disease progression in mCRC

Pfizer’s Braftovi (encorafenib) combination therapy was shown to reduce the risk of death by nearly half compared to standard of…
Capitalising on UK’s goal to become a world-leading clinical trial destination

Representatives of industry and regulation will meet in June to discuss paths forward for the UK’s clinical trials sector following…
Can AI replace medical writers? Experts say not immediately

AI is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but those using…
Amid deglobalising trade, experts seek AI safeguards for clinical trial supply

The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial…
Are European biopharma manufacturers ‘nearshoring’?

In step with international news in recent times, European pharma and biotech are leaning towards ‘nearshoring’, preferring domestic operations to…